BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15829289)

  • 1. Single chain antibody fragments for the selective targeting of antigens to dendritic cells.
    Demangel C; Zhou J; Choo AB; Shoebridge G; Halliday GM; Britton WJ
    Mol Immunol; 2005 May; 42(8):979-85. PubMed ID: 15829289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.
    Johnson TS; Mahnke K; Storn V; Schönfeld K; Ring S; Nettelbeck DM; Haisma HJ; Le Gall F; Kontermann RE; Enk AH
    Clin Cancer Res; 2008 Dec; 14(24):8169-77. PubMed ID: 19088032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
    Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
    J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DEC-205
    Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
    Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid monoclonal antibody generation via dendritic cell targeting in vivo.
    Berry JD; Licea A; Popkov M; Cortez X; Fuller R; Elia M; Kerwin L; Kubitz D; Barbas CF
    Hybrid Hybridomics; 2003 Feb; 22(1):23-31. PubMed ID: 12713687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
    Volckmar J; Knop L; Hirsch T; Frentzel S; Erck C; van Ham M; Stegemann-Koniszewski S; Bruder D
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Assay for Screening of Optimal Targets for Antigen-Delivery to Murine Dendritic Cells.
    Pugholm LH; Varming K; Agger R
    Scand J Immunol; 2015 Dec; 82(6):498-505. PubMed ID: 26331836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
    Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
    Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
    Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
    Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
    Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser-assisted epicutaneous immunization to target human skin dendritic cells.
    Tripp CH; Voit H; An A; Seidl-Philipp M; Krapf J; Sigl S; Romani N; Del Frari B; Stoitzner P
    Exp Dermatol; 2021 Sep; 30(9):1279-1289. PubMed ID: 33797121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.
    Cheong C; Choi JH; Vitale L; He LZ; Trumpfheller C; Bozzacco L; Do Y; Nchinda G; Park SH; Dandamudi DB; Shrestha E; Pack M; Lee HW; Keler T; Steinman RM; Park CG
    Blood; 2010 Nov; 116(19):3828-38. PubMed ID: 20668230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen.
    Saluja SS; Hanlon DJ; Sharp FA; Hong E; Khalil D; Robinson E; Tigelaar R; Fahmy TM; Edelson RL
    Int J Nanomedicine; 2014; 9():5231-46. PubMed ID: 25419128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of C-type lectin receptors by subsets of dendritic cells in human skin.
    Ebner S; Ehammer Z; Holzmann S; Schwingshackl P; Forstner M; Stoitzner P; Huemer GM; Fritsch P; Romani N
    Int Immunol; 2004 Jun; 16(6):877-87. PubMed ID: 15113774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants.
    Sartorius R; Bettua C; D'Apice L; Caivano A; Trovato M; Russo D; Zanoni I; Granucci F; Mascolo D; Barba P; Del Pozzo G; De Berardinis P
    Eur J Immunol; 2011 Sep; 41(9):2573-84. PubMed ID: 21688262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen targeting to dendritic cells with bispecific antibodies.
    Wang WW; Das D; Tang XL; Budzynski W; Suresh MR
    J Immunol Methods; 2005 Nov; 306(1-2):80-92. PubMed ID: 16202424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting with oligomannose-coated liposomes promotes maturation and splenic trafficking of dendritic cells in the peritoneal cavity.
    Ishii M; Kato C; Hakamata A; Kojima N
    Int Immunopharmacol; 2011 Feb; 11(2):164-71. PubMed ID: 21112331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting dendritic cells with antigen via dendritic cell-associated promoters.
    Moulin V; Morgan ME; Eleveld-Trancikova D; Haanen JB; Wielders E; Looman MW; Janssen RA; Figdor CG; Jansen BJ; Adema GJ
    Cancer Gene Ther; 2012 May; 19(5):303-11. PubMed ID: 22361816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.